PDF
ePub
Citation
Print
Abstract
Purpose
A study was conducted to evaluate the clinical characteristics of patients with postcoital hematuria without bloody ejaculate.
Materials and Methods
The records of 21 men (mean age 48.6 years, range 27-64 years) with isolated postcoital hematuria without bloody ejaculate were retrospectively reviewed. Patients underwent routine laboratory testing including coagulation studies and urological evaluation which included urinalysis, urine cytology, abdominal and transrectal ultrasonography, and cystourethroscopy.
Results
Among total 21 patients, there were no detectable abnormalities in 11 (52.4%) patients. Lesions were found in 10 (47.6%) patients, which included 1 pathologically proven prostatic urethral hemangioma, 5 benign prostatic hyperplasia, 1 bladder neck obstruction, and 3 ultrasonographi-cally identified seminal vesicle dilatation. In 19 (90.5%) patients, symptom subsided after treatment or simple observation without recurrences. In the remaining two patients, postcoital hematuria has still persisted intermittently.
REFERENCES
1. Ahmad I, Krishna NS. Hemospermia. J Urol. 2007; 177:1613–8.
2. Mulhall JP, Albertsen PC. Hemospermia: diagnosis and management. Urology. 1995; 46:463–7.
3. Ganabathi K, Chadwick D, Feneley RC, Gingell JC. Haemospermia. Br J Urol. 1992; 69:225–30.
4. Wang LJ, Tsui KH, Wong YC, Huang ST, Chang PL. Arterial bleeding in patients with intractable hematospermia and concomitant hematuria: a preliminary report. Urology. 2006; 68:938–41.
5. Cattolica EV. Massive hemospermia: a new etiology and simplified treatment. J Urol. 1982; 128:151–2.
6. Furuya S, Ogura H, Tanaka Y, Tsukamoto T, Isomura H. Hemangioma of the prostatic urethra: hematospermia and massive postejaculation hematuria with clot retention. Int J Urol. 1997; 4:524–6.
7. Hiraishi K, Fujisawa A, Kumagai H. A case of benign polyp with prostatic-like epithelium of the urethra. Jpn J Clin Urol. 1988; 42:831–3.
8. Cheng YS, Lin JS, Lin YM. Isolated posterior urethral injury: an unusual complication and presentation following male coital trauma. Asian J Androl. 2006; 8:379–81.
9. Redman JF, Young JW 3rd. Massive postejaculation hematuria. Urology. 1987; 30:73.
10. Aliabadi H, Cass AS, Gleich P. Utricular papilloma. Urology. 1987; 29:317–8.
11. Mi ZG, Yang XF, Liang XZ, Liu HY, Liu SY, Zhang H, et al. Adenoma of the posterior urethra: 131 case report. Asian J Androl. 2001; 3:67–70.
12. Kumar R, Kesarwani P, Shrivastava DN, Hemal AK. Post coital hematuria: presentation of an uncommon case. J Postgrad Med. 2004; 50:312–3.
13. Hong SJ, Park DW, Kim MJ, Lee DY. Transrectal color Doppler ultrasonography for postejaculation hematuria. Abdom Imaging. 1996; 21:551–3.
14. Tsui KH, Wang LJ, Chang PL, Huang ST, Hsieh ML, Lee SH. Hematuria from left internal pudendal and obturator arterial bleeding following sexual intercourse. Arch Androl. 2003; 49:453–5.
15. Chen YH, Lin PY, Cheng YS, Lin JS, Lin YM. Postcoital gross hematuria: an unusual presentation of benign prostatic hyperplasia. Asian J Androl. 2007; 9:856–8.
16. Pareek G, Shevchuk M, Armenakas NA, Vasjovic L, Hochberg DA, Basillote JB, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol. 2003; 169:20–3.
17. Donohue JF, Hayne D, Karnik U, Thomas DR, Foster MC. Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks. BJU Int. 2005; 96:1319–22.
18. Marks LS. 5α-reductase: history and clinical importance. Rev Urol. 2004; 6(Suppl 9):S11–21.
19. Cha GS, Yoo TK, Jo MK, Kim HS. Effects of dutasteride on the microvessel density of the prostate in BPH patients. Urology. 2007; 70(Suppl 3A):): 156, abstract MP-20.19.
20. Ahn HS. Transrectal ultrasonography of the prostate and seminal vesicles with hemospermia. J Korean Androl Soc. 1996; 14:91–4.
Table 1.
Characteristics of patients with postcoital hematuria without bloody ejaculate
| Patient No. | Age (years) | Symptom duration (months) | Identified lesions | Treatment | Persistence of symptom after first visit (months) | Follow-up (months) |
|---|---|---|---|---|---|---|
| 1 | 50 | 1 | Seminal vesicle dilatation | Observation | 1 | 12 |
| 2 | 36 | 7 | − | Antibiotic | 1 | 28 |
| 3∗ | 50 | 180 | − | Antibiotic, α-blocker | 74 | 74 |
| 4 | 53 | 1/4 | BPH | α-blocker, finasteride | 1 | 33 |
| 5 | 48 | 3 | BPH | α-blocker, finasteride | 1 | 41 |
| 6 | 47 | 1 | Prostatic urethral hemangioma | TUR | 2 | 11 |
| 7 | 63 | 2 | − | Observation | 1 | 17 |
| 8 | 46 | 12 | − | Antibiotic | 12 | 36 |
| 9 | 46 | 1/4 | BNO | α-blocker | 3 | 38 |
| 10 | 61 | 1 | − | Observation | 1 | 21 |
| 11 | 55 | 3/4 | Seminal vesicle dilatation | Observation | 1 | 27 |
| 12 | 55 | 1/4 | BPH | Finasteride | 3 | 18 |
| 13 | 63 | 1/4 | − | Antibiotic | 1 | 18 |
| 14 | 47 | 1/30 | − | Observation | − | 108 |
| 15 | 27 | 1/4 | − | Observation | 1/10 | 120 |
| 16 | 38 | 1/30 | − | Observation | − | 120 |
| 17 | 53 | 12 | − | Observation | 2 | 96 |
| 18 | 46 | 1/30 | Seminal vesicle dilatation | Antibiotic | 1/4 | 72 |
| 19∗ | 34 | 36 | − | Antibiotic | 19 | 19 |
| 20 | 38 | 1/2 | BPH | α-blocker | − | 10 |
| 21 | 64 | 1/4 | BPH | α-blocker, finasteride | − | 28 |
XML Download